N/A N=36 Randomized Single-blind Supportive Care

Advance Care Planning With Older Patients Who Have End-stage Kidney Disease

Kidney Failure, Chronic

Bottom Line

View on ClinicalTrials.gov: NCT02631200 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2024

Primary outcome: Primary: Kidney Disease Quality — 75.4; 78.3; 78.4; 73.4 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Advance care plan (Behavioral)
Age: Older Adult · 65+ yrs
Sex: All
Sponsor: Queen's University, Belfast
Primary completion: Jul 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Kidney Disease Quality	75.4; 78.3; 78.4; 73.4; 46.9; 55.2	—
SECONDARY Number of Participants With Agreement Between the Patient and Their Nominated Carer in Terms of the Patient's Preferences	10; 7; 7; 12; 7; 3	—
SECONDARY Depression	0.4; 0.4	—
SECONDARY The Degree to Which the Patient Felt That They Had Shared in Decision-making.	12; 11.2	—

Summary

This study will test the feasibility of carrying out a randomised controlled trial, incorporating a mixed methods process evaluation, to evaluate advance care planning with older patients who have end-stage kidney disease.

Eligibility Criteria

Inclusion Criteria

Attending the renal units taking part in the study
Receiving renal replacement therapy
Capacity to understand, retain, and weigh the necessary information and communicate their decisions
Identified by their consultant as having worsening symptoms, functional decline, and two or more co-morbidities.

Exclusion Criteria

Expected to die in the next three months

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02631200). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.